NPY has been implicated in neurodegenerative diseases such as Alzheimer’s disease, Huntington’s disease, and Parkinson’s disease as a biomarker, neuroprotective factor, or potential therapeutic target [25,32,58,133]. The gene discussed is NPY; the disease is early-onset autosomal dominant Alzheimer disease.